Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late? esagonowsky Mon, 01/31/2022 – 15:28 More: Novavax finally submits its COVID-19 vaccine to the FDA. Is it too late? Source: fierce
read moreAbbVie’s new migraine meds could each pull in $2B at peak thanks to class growth, analyst says kdunleavy Mon, 01/31/2022 – 13:24 More: AbbVie's new migraine meds could each pull in B at peak thanks to class growth, analyst says
read moreFDA commissioner nominee Califf makes ethics pledge to Sen. Warren in bid for her support: report fkansteiner Mon, 01/31/2022 – 12:54 More: FDA commissioner nominee Califf makes ethics pledge to Sen. Warren in bid for her support: report Source: fierce
read moreTwo Biogen board members depart as company struggles to get Aduhelm off the ground fkansteiner Mon, 01/31/2022 – 10:30 More: Two Biogen board members depart as company struggles to get Aduhelm off the ground Source: fierce
read moreRoche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea kdunleavy Mon, 01/31/2022 – 09:52 More: Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron's dominant Eylea Source: fierce
read moreVulnerable people at risk from COVID-19 are set to have access to game-changing Pfizer antiviral More: Second COVID-19 antiviral set for release Source: News
read more© 1994 - 2024 B.M. Pharmaceuticals